These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23075174)

  • 1. Reform, regulation, and pharmaceuticals--the Kefauver-Harris Amendments at 50.
    Greene JA; Podolsky SH
    N Engl J Med; 2012 Oct; 367(16):1481-3. PubMed ID: 23075174
    [No Abstract]   [Full Text] [Related]  

  • 2. Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI.
    Darrow JJ; Avorn J; Kesselheim AS
    N Engl J Med; 2017 Dec; 377(23):2278-2286. PubMed ID: 29211663
    [No Abstract]   [Full Text] [Related]  

  • 3. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 4. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commemorating the 50th anniversary of the Drug Amendments of 1962.
    Hutt PB; Temple R
    Food Drug Law J; 2013; 68(4):449-65. PubMed ID: 24552082
    [No Abstract]   [Full Text] [Related]  

  • 6. 1992 Le Tourneau Award. Problems with pharmaceutical regulation in the United States. Drug lag and orphan drugs.
    Henry V
    J Leg Med; 1993 Dec; 14(4):617-39. PubMed ID: 8308452
    [No Abstract]   [Full Text] [Related]  

  • 7. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2009 Apr; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract]   [Full Text] [Related]  

  • 8. Unapproved drugs in the United States and the Food and Drug Administration.
    Nasr A; Lauterio TJ; Davis MW
    Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA ten years after the Kefauver-Harris amendments.
    Hollister LE
    Perspect Biol Med; 1974; 17(2):243-9. PubMed ID: 4591497
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA Amendments Act of 2007 - Assessing Its Effects a Decade Later.
    Avorn J; Kesselheim A; Sarpatwari A
    N Engl J Med; 2018 Sep; 379(12):1097-1099. PubMed ID: 30231220
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of drugs and devices: an evolution.
    Merrill RA
    Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M
    N Engl J Med; 2007 Apr; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract]   [Full Text] [Related]  

  • 13. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA reform plan edges closer to realisation.
    Marx V
    Lancet; 2012 Jun; 379(9832):2135. PubMed ID: 22690392
    [No Abstract]   [Full Text] [Related]  

  • 15. Teaching clinicians about drugs--50 years later, whose job is it?
    Avorn J
    N Engl J Med; 2011 Mar; 364(13):1185-7. PubMed ID: 21449781
    [No Abstract]   [Full Text] [Related]  

  • 16. Fifty years of drug amendments revisited: in easy-to-swallow capsule form.
    Kaplan AH
    Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042
    [No Abstract]   [Full Text] [Related]  

  • 17. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution and revolution in drug labeling: regulation of antiarrhythmic drugs by the Food and Drug Administration 1962-1996.
    Pritchett EL
    Pacing Clin Electrophysiol; 1998 Jul; 21(7):1457-69. PubMed ID: 9670191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FDA and "privatization"--the drug approval process.
    Rutherford EM
    Food Drug Law J; 1995; 50 Spec():203-25. PubMed ID: 10343044
    [No Abstract]   [Full Text] [Related]  

  • 20. Coming closer to FDA reform.
    Cimmons M
    Nat Med; 1997 Sep; 3(9):940. PubMed ID: 9288707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.